Background: Myocardial damage due to ischemia and reperfusion is still unavoidable during coronary surgery. Anesthetic agents have myocardial preconditioning effect. Ketamine has sympathomimetic effect, while dexmedetomidine has a sympatholytic effect in addition to anesthetic, analgesic, and anti-inflammatory properties of both the drugs. This study was carried out to compare ketamine–dexmedetomidine (KD) combination with fentanyl–propofol (FP) combination on the release of cardiac troponin T (cTnT) and outcome after coronary artery bypass graft. Patients and Methods: Ninety adult patients who underwent coronary artery bypass grafting (CABG) were assigned to receive either KD base anesthesia (KD group) or FP anesthesia (FP group). Trends of high-sensitive cTnT, CK-MB, and serum cortisol were followed in the first postoperative 24 h. Other outcomes were vital signs, weaning from cardiopulmonary bypass, tracheal extubation time, and echocardiographic findings. Results: There was a significant lower release of cTnT in KD group than FP group during its peak values at 6 h after aortic unclamping (92.01 ± 7.332 in KD versus 96.73 ± 12.532 ng.L −1 P = 0.032). significant lower levels of serum cortisol levels were noted KD group than in FP group at 6 and 12 h after aortic unclamping P < 0.001. As regard tracheal extubation time, patients assigned to KD group extubated earlier than whom in FP group 202.22 ± 28.674 versus 304.67 ± 40.598 min respectively P < 0.001. Conclusion: The use of KD during on-pump CABG confers better myocardial protective and anti-inflammatory effect than fentanyl propofol.
Background: Psoriasis is a common inflammatory disorder of the skin. Psoriasis is a disease of multifactorial origin where certain environmental factors acting on individuals with specific genetic predisposition leads to an immune dysregulation. Claudins are transmembrane proteins, which participate in the formation of tight junctions by binding to the actin cytoskeleton. Claudin-3 present in the blood is considered as a useful biomarker of intestinal permeability. Objective: To evaluate serum level of claudin-3 in patients with psoriasis in comparison to control group and correlate its levels with disease severity . Patients and methods: Fifty-three patients (32 males and 21 females) with psoriasis and forty normal healthy control (23 males and 17 females) who matched the cases group as regard age and sex were included in this work. They were randomly selected from the Dermatology Department outpatient clinic in Mansoura University Hospital. Results: Psoriasis group showed significantly higher level of claudin-3 when compared to control group (mean=58.3 versus 41.2; p<0.001). Smoking was significantly associated with higher Claudin-3 level (p=0.031). In addition, claudin-3 level increased gradually with increased severity grades (p<0.001). No significant associations were found regarding claudin-3 level according to gender, nutritional status, family history, in psoriasis group (p>0.05 for each). Higher BMI, smoking and higher claudin-3 level were associated with prediction of higher PASI score in univariate analysis. While multivariate analysis revealed that only smoking and higher claudin-3 level were considered independent predictor of more severe psoriasis cases. Conclusion: Claudin-3 level was significantly higher in patients with psoriasis than healthy controls. PASI correlated with claudin-3 levels.
<abstract> <p>The <italic>pks</italic> genotoxic <italic>K. pneumoniae</italic> has recently triggered a widespread alarm. DNA damage and higher virulence have been linked to colibactin, a genotoxin expressed by the <italic>pks</italic> genomic island. Little is known about its molecular epidemiology in clinical isolates from Egypt. Therefore, this study was conducted to determine the prevalence and the microbiological and clinical features of <italic>pks</italic> harboring hospital-acquired <italic>K. pneumoniae</italic> isolates from Egypt. Eighty-seven hospital-acquired <italic>K. pneumoniae</italic> isolates from various specimen types were screened for <italic>pks</italic> colibactin island markers <italic>clbB</italic>, <italic>clbQ</italic>, <italic>clbA</italic>, and <italic>clbN</italic> by PCR. The <italic>pks</italic>-positive hvKp isolates were classified to one of the capsular types K1 and K2 using multiplex-PCR targeting <italic>K</italic>-serotype <italic>wzi</italic> and <italic>rmpA</italic> genes. The prevalence of <italic>pks<sup>+</sup></italic> strains was 27.6% (24/87). K1 capsular type, phenotypic, and genotypic hypervirulent isolates were significantly higher among <italic>pks<sup>+</sup></italic> strains than <italic>pks<sup>−</sup></italic> strains (<italic>P</italic> < 0.001), while <italic>pks<sup>+</sup> K. pneumoniae</italic> strains were found to be significantly less resistant to 8 of the antibiotic compounds tested than <italic>pks<sup>−</sup></italic> strains. Carriage of K1 capsular type and mucoviscosity-associated <italic>rmp A</italic> gene and diabetes mellitus were identified to remain independent risk factors having a substantial association to <italic>pks</italic>-positivity by multivariate regression analysis. In conclusion, Hospital-acquired <italic>K. pneumoniae</italic> isolates in Egypt had an increased prevalence of the <italic>pks</italic> colibactin genotoxin. The significant occurrence of hypervirulent determinants in <italic>pks<sup>+</sup> K. pneumoniae</italic> highlighted the genotoxin's possible pathogenicity combined with its distribution in several specimen types, which necessitates clinical attention and epidemic tracking.</p> </abstract>
Background: In hepatocellular carcinoma (HCC), CK19 is a marker of hepatic progenitor cells and acts as a key player in tumor invasion, indicating poor prognosis. Early diagnosis of HCC heavily affects the clinical outcome of patients. The widely accepted serological marker for HCC diagnosis is alpha-fetoprotein (AFP). However, its diagnostic accuracy is controversial and unsatisfactory because of its low sensitivity. The objective of the current study is to evaluate the influence of CK19 level on Pattern of HCC in patients with liver cirrhosis. Patients and methods: This was a prospective case -control study that was conducted on patients attending at early detection of HCC Outpatient Clinic or admitted to Hepatology and Gastroenterology Unit, Specialized Medical Hospital Mansoura University, over past year. The current study included 75 participants divided into 3 groups: Group 1 (HCC), Group 2 (cirrhosis only) and Group 3 (healthy people without any medical disease). Results: There was statistically significant increase as regard median CK19 level, between degrees of aggressiveness index (A, B and C) (P >0.05). Regarding the validity of CK19 in differentiating the studied groups, there was no statistically significant difference as regard median CK19 level in cirrhosis and control groups with Sensitivity 56% and Specificity 40%. There was no statistically significant difference as regard median CK19 level in HCC and control groups with Sensitivity 64% and Specificity 40%. There was no statistically significant difference as regard median CK19 level in HCC and cirrhosis groups with Sensitivity 64% and Specificity 44%. There is weak significant relationship between the levels of CK19 and AFP in HCC cases (P-value 0.07). Conclusion: CK19 associated carry a poor prognosis as it associated with more aggressive pattern of HCC. CK19 is good negative marker of early HCC, So CK19 negative HCC patients has no priority for treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.